Phase III Study on HMPL-523 for Treatment of ITP

Clinical trial NCT05029635 · COMPLETED

Trial details

NCT number: NCT05029635
Sponsor: Hutchmed
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Immune Thrombocytopenia (ITP)

Start date: 2021-10-27
Primary completion: 2025-05-16
Enrollment: 272

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.